DUPUYTRENS DISEASE Michael Mara MD FRCSI FAAOS MAGA DUPUYTRENS - - PowerPoint PPT Presentation

dupuytren s disease
SMART_READER_LITE
LIVE PREVIEW

DUPUYTRENS DISEASE Michael Mara MD FRCSI FAAOS MAGA DUPUYTRENS - - PowerPoint PPT Presentation

DUPUYTRENS DISEASE Michael Mara MD FRCSI FAAOS MAGA DUPUYTRENS DISEASE A Systemic Non-Malignant Fibroproliferative Disorder Fibroproliferative Disorder may Affect: The Hand: nodules, cords, Garrods knuckle pads The


slide-1
SLIDE 1

DUPUYTREN’S DISEASE

Michael Mara MD FRCSI FAAOS

slide-2
SLIDE 2

MAGA

slide-3
SLIDE 3

DUPUYTREN’S DISEASE

  • A Systemic Non-Malignant

Fibroproliferative Disorder

  • Fibroproliferative Disorder may

Affect:

  • The Hand: nodules, cords,

Garrod’s knuckle pads

  • The Feet: Lederhosen

Syndrome

  • The Penis: Peyronei's

Disease

slide-4
SLIDE 4

DUPUYTREN’S DISEASE RISK FACTORS

  • Male>>Female
  • Caucasian
  • Scandinavian/Northern European

Ancestry

  • Age>50
  • Family History
  • Diabetes
  • Little Data to support epilepsy, seizure

meds, trauma, industrial

slide-5
SLIDE 5

BARON GUILLAUME DUPUYTREN 1777-1835

slide-6
SLIDE 6

DUPUYTREN’S DIATHESIS

Diat athe hesis sis: a constitutional predisposition toward a particular state or condition Dupuytren’s Diathesis:

  • Greater genetic “load” and penetrance
  • Aggressive systemic form of the disease
slide-7
SLIDE 7

DUPUYTREN’S DIATHESIS

  • <50 years old
  • Family History
  • Bilateral involvement
  • Multiple Digits
  • Thumb Involvement
  • Ectopic Involvement
  • Rapid Progression
slide-8
SLIDE 8

DUPUYTREN’S DIATHESIS

  • Very High Recurrence Rates

with traditional treatments

  • Careful Patient Counselling
  • Very conservative or very

aggressive treatment may be employed

slide-9
SLIDE 9

DUPUYTREN’S CONTRACTURE STAGING

  • Stage 0: Normal Hand
  • Stage N: Nodule Only
  • Stage 1: Contracture 0-45
  • Stage 2: Contracture 46-90
  • Stage 3: Contracture 91-135
  • Stage 4: Contracture >135
slide-10
SLIDE 10

NEEDLE APONEUROTOMY

  • Inexpensive
  • Low complications rate
  • Rapid Recovery
  • Local Anaesthesia
  • Side Room or Clinic Setting
  • High Recurrence Rates (50% at 3 years)
  • Expensive
  • Minor Wound Complications common
  • Serious nerve / artery complications 1%
  • Prolonged Recovery
  • General / Regional Anaesthesia
  • Operating Theatre
  • Lowest Recurrence Rates

SURGERY

TREATMENT

slide-11
SLIDE 11

NEEDLE APONEUROTOMY

  • Local Anesthesia, Clinic or Side Room Setting
  • Multiple Passes through Dupuytren’s Cord with

25g needle

  • Minimal Pain,

Very Rapid Recovery

  • Can be repeated when needed
  • Nerve/Tendon Injury rates < 1%
  • Early Recurrence Common
slide-12
SLIDE 12

REGIONAL PALMAR FASCIECTOMY

  • Day Surgery or One Night Stay
  • Early Hand Therapy for Splinting

and Range of Motion, Edema Control

  • Low Recurrence Rates for MP

joint contracture, Moderate Recurrence Rates for PIP joint Contracture

  • Note: Collagenase Clostridium

Histolyticum (CCH, Xiapex) Discontinued European Distribution January 2020

slide-13
SLIDE 13

POST-OP CARE

  • Surgical Bandages Removed at 72 hours
  • Hand Therapy for Thermoplastic Splinting

and

  • Early ROM for most cases, delayed 10

days if FTSG

  • Suture Removal at 14 days
slide-14
SLIDE 14

WHEN TO REFER: TABLE-TOP TEST

slide-15
SLIDE 15

THANK YOU! ANY QUESTIONS?

slide-16
SLIDE 16
slide-17
SLIDE 17

TMTEL.ORG

slide-18
SLIDE 18

MYCOBACTERIUM LEPRAE